尽管未能获得收益，但 McKesson 的股票得到了提振，摩根士丹利的新目标价为 745 美元。 McKesson's stock gets a boost despite missing earnings, with a new target price of $745 by Morgan Stanley.

McKessson公司(NYSE:MCK)是一家主要的医疗保健服务公司,最近看到 " 团结财富伙伴 " 和 " 峰会金融 " 等公司的投资增加,摩根斯坦利将价格目标提高到745.00美元。 McKesson Co. (NYSE:MCK), a major healthcare services firm, recently saw increased investment from firms like Uniting Wealth Partners and Summit Financial, along with a price target hike by Morgan Stanley to $745.00. 尽管缺少收入预期,但McKessson仍获得“机动买”共识评级,目标价格为656.71美元。 Despite missing earnings expectations, McKesson has a "Moderate Buy" consensus rating and a target price of $656.71. 该公司的股票价值为每股694.12美元,市场上限为86.99亿美元。 The company's stock is valued at $694.12 per share, with a market cap of $86.99 billion.